Antipodes Partners’s Citigroup C Stock Holding History

Antipodes Partners’s Portfolio C Stock Details C Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-33,559	Closed	-$2.24M	–	29
2017 Q2	$2.24M	Buy	+33,559	New	+$2.06M	0.3%	20

Other funds holding C

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Antipodes Partners's C Position: Q3 2017 in Review

Antipodes Partners sold out of Citigroup (C) in Q3 2017, closing a stake of 33,559 shares — an estimated $2.24M sold.

Antipodes Partners first reported a position in C in Q2 2017 and held it in 1 quarter. The position peaked at $2.24M in Q2 2017. 1,470 funds tracked by Wall St. Rank hold C as of Q3 2017.

Antipodes Partners reported no remaining Citigroup position as of Q3 2017 after selling out during the quarter.
Antipodes Partners sold 33,559 Citigroup shares in Q3 2017, an estimated $2.24M.
Antipodes Partners first reported a position in Citigroup in Q2 2017 and held it in 1 quarter.
Antipodes Partners's Citigroup position peaked at $2.24M in Q2 2017.
1,470 funds tracked by Wall St. Rank held Citigroup as of Q3 2017.

Based on Antipodes Partners's 13F filing for Q3 2017, filed 12 Oct 2017.